Nice win. Certainly feels like there is still a fair bit of blue sky potential from SSK. Yet the market is still pricing it as a value stock
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025